id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-5585-0005,FDA,FDA-2019-D-5585,Bridging for Drug-Device and Biologic-Device Combination Products; Draft Guidance for Industry; Availability; Extension of Comment Period,Notice,Extension of Comment Period,2020-02-14T05:00:00Z,2020,2,2020-02-14T05:00:00Z,2020-04-21T03:59:59Z,2020-02-21T13:52:28Z,2020-03023,0,0,09000064843694ef
FDA-2019-D-5585-0004,FDA,FDA-2019-D-5585,Request for Extension from Biotechnology Innovation Organization (BIO),Other,Request for Extension,2020-01-14T05:00:00Z,2020,1,2020-01-14T05:00:00Z,,2020-01-14T16:36:15Z,,0,0,090000648429b911
FDA-2019-D-5585-0003,FDA,FDA-2019-D-5585,Request for Extension from Combination Products Coalition,Other,Request for Extension,2020-01-13T05:00:00Z,2020,1,2020-01-13T05:00:00Z,,2020-01-13T16:03:34Z,,0,0,0900006484291ce5